RNA vaccine candidate(s) against SARS-CoV-2
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RNA vaccine candidate(s) against SARS-CoV-2, covering 2026-03-25 to 2026-03-25. Get the full timeline:
Most recent: Clinical Trial Update: Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals [Phase 2, Phase 3]